Infusyn Therapeutics

Infusyn Therapeutics manufactures the Prometra II, an implantable, fully programmable drug delivery system designed for precise, targeted therapeutic administration. The Prometra II features Infusyn's proprietary Precision Dosing System (PDS), engineered to deliver medication with exceptional accuracy while minimizing variability from reservoir volume, temperature, and pressure fluctuations. Currently FDA-approved for pain and spasticity management, the system enables physicians to achieve individualized, flexible dosing regimens with unrivaled consistency. Infusyn is expanding Prometra applications across multiple therapeutic indications through strategic partnerships, including development for pulmonary arterial hypertension (PAH). The company serves hospital systems, specialty clinics, and pain management centers requiring implantable infusion solutions with superior dosing reliability and patient-centric programmability.